HIGH-DOSE CYCLOPHOSPHAMIDE, ETOPOSIDE AND BCNU WITH NON-CRYOPRESERVED AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANTATION FOR POOR PROGNOSIS HODGKIN'S LYMPHOMA

被引：0
|
作者：
Brahimi, M. [1 ]
Yafour, N. [1 ]
Osmani, S. [1 ]
Attaf, F. [1 ]
Tadj, H. [1 ]
Arabi, A. [1 ]
Soltan, B. Enta [1 ]
Berredouane, H. [1 ]
Benzineb, B. [1 ]
Bey, M. [1 ]
Bahlat, N. [1 ]
Bekadja, M. A. [1 ]
机构：
[1] Univ Hosp Oran 1st November, Oran, Algeria
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2010年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1672
引用
收藏
页码：655 / 656
页数：2
相关论文
共 50 条
  • [21] Double high-dose therapy for Hodgkin's disease with dose-intensive cyclophosphamide, etoposide, and cisplatin (DICEP) prior to high-dose melphalan and autologous stem cell transplantation
    Stewart, DA
    Guo, D
    Glück, S
    Morris, D
    Chaudhry, A
    deMetz, C
    Klassen, J
    Brown, CB
    Russell, JA
    BONE MARROW TRANSPLANTATION, 2000, 26 (04) : 383 - 388
  • [22] Long-term outcomes of high-dose etoposide and melphalan chemotherapy and autologous stem cell transplantation for non-Hodgkin lymphoma
    Kuruvilla, J.
    Zadeh, S.
    Franke, N.
    Nagy, T.
    Saragosa, R.
    Crump, M.
    Keating, A.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S148 - S149
  • [23] Autologous stem cell transplantation for relapsed/refractory Hodgkin's disease using Cyclophosphamide, Etoposide, BCNU and ± Platinum.
    Lerner, D
    Tavares, RB
    De Lima, MG
    Bouzas, LF
    Da Matta, JR
    Melo, T
    Byington, R
    Tabak, D
    BLOOD, 1999, 94 (10) : 402B - 402B
  • [24] High dose chemotherapy and autologous stem cell transplantation in poor-prognosis Hodgkin's disease
    Patti, C
    Cavallaro, A
    Tringali, S
    Indovina, A
    Santoro, A
    Costa, A
    Pagano, M
    Cascio, L
    Scimè, R
    BONE MARROW TRANSPLANTATION, 2001, 27 : S265 - S265
  • [25] High-dose etoposide, cytarabine and melphalan as conditioning regimen for autologous stem cell transplantation in patients with refractory or relapsed Hodgkin's lymphoma
    Bekadja, M. A.
    Osmani, S.
    Brahimi, M.
    Talhi, S.
    Bekadja, S.
    Belkhodja, S.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S446 - S446
  • [26] High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk Hodgkin's lymphoma
    Di Ianni, Mauro
    Ballanti, Stelvio
    Iodice, Giuseppe
    Reale, Antonia
    Falzetti, Franca
    Minelli, Olivia
    Serio, Gabriella
    Martelli, Massimo F.
    Dammacco, Franco
    Vacca, Angelo
    Ria, Roberto
    HEMATOLOGY, 2012, 17 (01) : 23 - 27
  • [27] High-dose chemotherapy with busulfan and cyclophosphamide and autologous stem cell rescue in patients with Hodgkin lymphoma
    Lane, Andrew A.
    Mcafee, Steven L.
    Kennedy, Joanne
    Dube, Christine
    Attar, Eyal C.
    Ballen, Karen K.
    Dey, Bimalangshu R.
    Spitzer, Thomas R.
    Chen, Yi-Bin
    LEUKEMIA & LYMPHOMA, 2011, 52 (07) : 1363 - 1366
  • [28] Upfront double high-dose chemotherapy with DICEP followed by BEAM and autologous stem cell transplantation for poor-prognosis aggressive non-Hodgkin lymphoma
    Stewart, Douglas A.
    Bahlis, Nizar
    Valentine, Karen
    Balogh, Alex
    Savoie, Lynn
    Morris, Donald G.
    Jones, Allan
    Brown, Chris
    Russell, James A.
    BLOOD, 2006, 107 (12) : 4623 - 4627
  • [29] Tandem high dose chemotherapy for non-Hodgkin's lymphoma and Hodgkin's disease utilizing cyclophosphamide, etoposide and carboplatin followed by melphalan and carboplatin with autologous stem cell transplantation.
    Andrey, J
    Burian, C
    McMillan, R
    Miller, WE
    Meisenberg, B
    Mason, JR
    BLOOD, 2000, 96 (11) : 367B - 367B
  • [30] HIGH-DOSE CARBOPLATIN, ETOPOSIDE AND IFOSFAMIDE AND AUTOLOGOUS STEM-CELL RESCUE IN THE TREATMENT OF NON-HODGKIN LYMPHOMA
    SIEGERT, W
    PATHOLOGIE BIOLOGIE, 1993, 41 (01): : 104 - 104
12345